Dr. Karen Laszlo Keller, MD

Dr. Keller practices at Burlingame Surgical Center Inc in Burlingame, California.

Dr. Keller's NPI, 1437157054, was assigned on July 8, 2005. Dr. Keller graduated from University of Miami, Miller School of Medicine in 1994. Dr. Keller holds California license A67381.

Dr. Keller's primary practice is Burlingame Surgical Center Inc, at 1750 El Camino Real, Burlingame, CA 94010 in San Mateo County. The practice phone is (650) 259-1480.

Dr. Keller's primary practice is Burlingame Surgical Center Inc in Burlingame, California. Dr. Keller is also affiliated with Mills-Peninsula Medical Center. The medical group on file is Peninsula Dermatology. Dmand AI also links Dr. Keller to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keller practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Keller's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Keller is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Keller's licenses on file in 2 states: California and Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Keller treats.

CMS data shows 3,952 Medicare services from Dr. Keller across 15 procedure codes in 2024, for 615 Medicare patients. Medicare paid $244,027 for them. Every service was in an office.

CMS counts 615 Medicare patients who saw Dr. Keller in 2024. The largest group is 65 to 74, with 288 patients. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Keller's median patient age at 60, with 65% women.

In 2024, Dr. Keller wrote 816 Medicare Part D claims for 358 patients. 92% of them were for generic drugs. CMS names the drug for 608 of them, across 17 drugs with 11 or more claims each, at $125,600 in total drug cost. In 2023, CMS named 462 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Keller for performance year 2024, reported as part of a group. Dr. Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 449 procedures of skin biopsy by Dr. Keller, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Keller.

CMS Open Payments shows 381 general payments to Dr. Keller from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,138.

Dmand AI lists 1 award for Dr. Keller.

Dr. Keller graduated from University of Miami, Miller School of Medicine in 1994. Dr. Keller is a member of AAD.

Dr. Keller is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.